SunBio is a biotechnology company established in June of 1997. SunBio specializes in drug discovery through development of biotechnological expertise. Its core businesses are in three areas:(1) New drug discovery technology, (2) PEG technology, (3) DNA technology.The capital of SunBio is 1,150,000,000 Won of which approximately 55% is owned by its founder, Kwang Nho, Ph.D., and 20% by Kookmin Venture Capital Company, and the rest by a group of individual investors. SunBio is located in Ansan City, South Korea where it houses headquarter, laboratory and manufacturing facilities. SunBio also operates a marketing office in California, USA.